Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.1215
+0.0045 (3.85%)
At close: Sep 4, 2026
Avaí Bio Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -1.81 | -1.75 | -1.14 | -2.13 | -0.35 | -0.13 |
Depreciation & Amortization | 0.02 | 0.03 | 0.07 | 0.08 | 0.02 | 0.04 |
Other Operating Activities | - | - | - | - | -0 | -0.01 |
Change in Accounts Receivable | - | - | - | - | 0 | 0.06 |
Change in Accounts Payable | 0.61 | 0.71 | -0.2 | 0.84 | 0.04 | -0.27 |
Change in Income Taxes | - | - | - | - | - | 0 |
Change in Other Net Operating Assets | -0 | 0.01 | 0.1 | -0.12 | 0.23 | -0.23 |
Operating Cash Flow | -1.18 | -1.01 | -1.16 | -1.32 | -0.05 | -0.54 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Acquisitions | -0.06 | - | - | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -0.15 | -0.03 | - |
Other Investing Activities | - | - | - | - | - | 0.03 |
Investing Cash Flow | -0.06 | - | - | -0.15 | -0.03 | 0.03 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 0.89 | 0.3 | 0.16 | 0.21 | 0.47 |
Total Debt Issued | 1.17 | 0.89 | 0.3 | 0.16 | 0.21 | 0.47 |
Short-Term Debt Repaid | - | - | -0.1 | -0.09 | -0.18 | - |
Total Debt Repaid | 0.1 | - | -0.1 | -0.09 | -0.18 | - |
Net Debt Issued (Repaid) | 1.27 | 0.89 | 0.2 | 0.07 | 0.04 | 0.47 |
Issuance of Common Stock | 0.58 | 0.5 | 1.04 | 1.27 | 0.12 | - |
Other Financing Activities | -0.54 | -0.44 | - | - | - | - |
Financing Cash Flow | 1.32 | 0.95 | 1.24 | 1.36 | 0.16 | 0.47 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 0.07 | -0.06 | 0.08 | -0.11 | 0.07 | -0.03 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.18 | -1.01 | -1.16 | -1.32 | -0.05 | -0.54 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -19.71% | -58.07% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 |
Levered Free Cash Flow | -0.55 | -0.41 | -1.01 | -0.67 | 0.05 | -0.24 |
Unlevered Free Cash Flow | -0.31 | -0.25 | -0.98 | -0.67 | 0.05 | -0.24 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Change in Working Capital | 0.61 | 0.71 | -0.09 | 0.73 | 0.27 | -0.43 |